Patients Squeezed in Fight Over Who Gets to Bill for Pricey Infusion Drugs
(By Samantha Liss for KFF Health News) Health insurers and medical providers are battling over who should supply high-cost infusion
Read More
Health Care Finance
Payment cuts did not reduce Medicare Advantage enrollment: Study
(By Rylee Wilson for Becker’s Hospital Review) Cuts in Medicare Advantage benchmark payments did not lead to slower growth in
Read MorePrivately Insured People with Depression and Anxiety Face High Out-of-Pocket Costs
(By Hope Schwartz, Nirmita Panchal, Gary Claxton, and Cynthia Cox for The Kaiser Family Foundation published: Jun 23, 2023) Millions
Read MoreOIG: Medicare overpaid up to $888M for genetic tests
(By Rylee Wilson for Becker’s Hospital Review) Medicare could have overpaid hundreds of millions for genetic testing from 2018 to
Read MoreStates ranked by healthcare affordability
(By Rylee Wilson for Becker’s Hospital Review) Texas is the worst state for healthcare access and affordability, according to a
Read MoreDementia Can Take a Toll on Financial Health, as Some Families Learn the Hard Way
By Sara Boden, WESA on June 20, 2023 for Kaiser Family Foundation Angela Reynolds knew her mother’s memory was slipping,
Read MoreCMS: Private insurance spending to increase in 2023, 2024; slow in 2025 onward
(By Rylee Wilson for Becker’s Hospital Review) CMS is projecting a 7.7 percent increase in private health insurance spending in
Read MoreThe current Medicare Advantage payment structure results in overpayments
Current research states that the millions of beneficiaries in traditional Medicare who have switched to Medicare Advantage plans have lower
Read MoreA loved one’s dementia will break your heart. Don’t let it wreck your finances
(By Sarah Boden for NPR) Sharon Gwinn had been married almost 30 years when she cleared out the savings and
Read MoreInflation Reduction Act Continues to Lower Out-of-Pocket Prescription Drug Costs for Drugs with Price Increases Above Inflation
(Source – cms.gov/newsroom) A continuing key priority of the Biden-Harris Administration is lowering prescription drug costs. Today, the Department of
Read More